23.4 C
New York
Monday, June 15, 2026

Tag: society

newssourceFORcompanyinformationcontent1marketreleases

MBL Announces Largest Ever Gift for Its Renowned Biological Education and Research Programs

Cell Biology Researcher Mark Terasaki's $25 Million Unrestricted Gift Will Support Operations and Infrastructure WOODS HOLE, Mass., July 28, 2025 /PRNewswire/ -- The Marine Biological Laboratory...

World Whiskey Society Highlights Straight Kentucky Bourbon Modern Bottle Aged 9 Years

A New Core Expression Showcasing Kentucky Craftsmanship With a Contemporary Design NEW YORK, July 28, 2025 /PRNewswire/ -- World Whiskey Society (WWS), an ultra-premium collection...

Crave Brothers Recognized with Three Top Awards at 2025 American Cheese Society Judging & Competition

Mascarpone and Oaxaca Knot receive first-place honors in a competitive national field WATERLOO, Wis., July 28, 2025 /PRNewswire/ -- Crave Brothers Farmstead Cheese LLC brought...

Cielo Announces Closing of First Tranche of Unit Offering and Closing of Securities for Debt Transactions

Cielo Announces Closing of First Tranche of Unit Offering and Closing of Securities for Debt Transactions

Interventional Robot’s RCT Research Published in JNIS, a Leading Journal in Neurointervention!

SHANGHAI, July 28, 2025 /PRNewswire/ -- The multicenter, randomized controlled trial (RCT) results of the PANVIS-A® NeuroInterventional Robotic System—led by Professor Liu Jianmin (Changhai Hospital)...

Carlsberg Asia Unites Football Fans in a Legendary Celebration of Liverpool FC

Fans across Asia rally for a week-long tribute to The Reds, culminating in a triumphant match and unforgettable Carlsberg experiences HONG KONG, July 28, 2025...

Consortium Led by Nordic Capital and Permira Will Make All-Cash Recommended Purchase Offer for Bavarian Nordic

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

Roche presents new insights in Alzheimer’s disease research across its diagnostics and pharmaceutical portfolios at AAIC

Basel, 28 July 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data from its Alzheimer’s development portfolio is being presented at the Alzheimer’s Association International Conference (AAIC) in Toronto, Canada (July 27-30). These data exemplify the comprehensive approach Roche is taking in addressing Alzheimer’s across the entire patient journey. 

Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025

SHANGHAI and HONG KONG, July 28, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...

Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025

SHANGHAI and HONG KONG, July 27, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...

NurExone Biologic Finalist in Falling Walls Venture 2025 Global Platform Showcasing The World’s Most Promising Science-Based Start-Ups

Company to compete for “Science Breakthrough of the Year” at Europe’s leading deep-tech summit in Berlin, Germany this November 
Company to compete for “Science Breakthrough of the Year” at Europe’s leading deep-tech summit in Berlin, Germany this November

Gundam Wing 30th Anniversary Shines at San Diego Comic-Con 2025

SDCC Panel Unveils Major Milestones for the Franchise That Brought Gundam to America and Sets the Stage for What's Next LOS ANGELES, July 25, 2025...

Allspring Closed-End Funds Declare Monthly Distributions and Announce a Portfolio Manager Change

CHARLOTTE, N.C., July 25, 2025 /PRNewswire/ -- The Allspring Income Opportunities Fund (NYSE American: EAD), the Allspring Multi-Sector Income Fund (NYSE American: ERC), and...

Evaxion to present two-year clinical efficacy data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025

COPENHAGEN, Denmark, July 25, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will be presenting two-year clinical efficacy data from its phase 2 trial with lead compound EVX-01 at the European Society for Medical Oncology (ESMO) Congress 2025 to be held in Berlin, Germany, from October 17-21, 2025.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSociety

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers